Loading company…
Riskpilot
← Back to search
Sign in
Get full access
VeroMedica AB
AB
Active
Org 5593403792
Kägelstigen 14
General medical practice activities · NACE 8621
Est. 2021
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 68K
-27% vs 2023
EBITDA margin
8.8%
-54% vs 2023
Equity ratio
70.5%
Financial strength
Net profit 2024
SEK 5K
-55% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 68K
-27%
EBITDA
SEK 6K
-54%
Net profit
SEK 5K
-55%
Total assets
SEK 44K
-27%
Equity
SEK 31K
+15%
Employees
0
—
Company information
Legal name
VeroMedica AB
Org number
5593403792
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
13 oktober 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Behandling och konsultverksamhet inom hälso- och sjukvård
Contact
Address
Kägelstigen 14
Email
axel.ahlund1@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Örebro
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2022
2023
2024
Revenue
90
93
68
Staff expenses
—
—
—
EBITDA
−9
13
6
Depreciation & amort.
−0
−0
−0
EBIT
−9
13
6
Net financials
—
—
—
Profit before tax
−9
14
6
Tax
−0
−3
−1
Net profit
−9
11
5
Balance sheet
SEK thousands
Item
2022
2023
2024
Total assets
33
60
44
Equity
16
27
31
Long-term debt
0
0
0
Short-term debt
17
33
13
Total debt
17
33
13
Financial ratios
5-year trend
EBITDA margin
8.8%
This company
15.8%
Market median
-44% vs market
2022
2024
Equity ratio
70.5%
This company
38.2%
Market median
+85% vs market
2022
2024
Return on equity
16.1%
This company
18.4%
Market median
+12% vs market
2022
2024
Net profit margin
7.4%
This company
8.1%
Market median
-9% vs market
2022
2024
Asset turnover
1.55×
This company
1.12×
Market median
+38% vs market
2022
2024
Debt / equity
0.42×
This company
0.62×
Market median
+32% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
AH
Axel Henri Lindberg
Board of Directors
2021
VG
Veronica Gladys Maria Ahlund
Board of Directors
2021
BE
Bengt Erik Johan Ahlund
Chairman
2021
GA
Gladys Ahlund
Board of Directors
2021
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of VeroMedica AB also hold positions in
0
other companies.
Person
Role here
Other companies
Axel Henri Lindberg
Board of Directors
0 companies
Veronica Gladys Maria Ahlund
Board of Directors
0 companies
Bengt Erik Johan Ahlund
Chairman
0 companies
Gladys Ahlund
Board of Directors
0 companies